95 related articles for article (PubMed ID: 31094292)
21. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
22. Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes.
Cullati SN; Chaikuad A; Chen JS; Gebel J; Tesmer L; Zhubi R; Navarrete-Perea J; Guillen RX; Gygi SP; Hummer G; Dötsch V; Knapp S; Gould KL
Mol Cell; 2022 Jun; 82(11):2006-2020.e8. PubMed ID: 35353987
[TBL] [Abstract][Full Text] [Related]
23. DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system.
Clarke CA; Clarke PR
Biochem J; 2005 Jun; 388(Pt 2):705-12. PubMed ID: 15707391
[TBL] [Abstract][Full Text] [Related]
24. Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.
Sillibourne JE; Milne DM; Takahashi M; Ono Y; Meek DW
J Mol Biol; 2002 Sep; 322(4):785-97. PubMed ID: 12270714
[TBL] [Abstract][Full Text] [Related]
25. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2.
Guerra B; Issinger OG; Wang JY
Oncogene; 2003 Aug; 22(32):4933-42. PubMed ID: 12902976
[TBL] [Abstract][Full Text] [Related]
27. Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).
Xu P; Ianes C; Gärtner F; Liu C; Burster T; Bakulev V; Rachidi N; Knippschild U; Bischof J
Gene; 2019 Oct; 715():144005. PubMed ID: 31376410
[TBL] [Abstract][Full Text] [Related]
28. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
[TBL] [Abstract][Full Text] [Related]
29. CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application.
Winkler BS; Oltmer F; Richter J; Bischof J; Xu P; Burster T; Leithäuser F; Knippschild U
Front Cell Dev Biol; 2015; 3():9. PubMed ID: 25750912
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit.
Leung-Pineda V; Ryan CE; Piwnica-Worms H
Mol Cell Biol; 2006 Oct; 26(20):7529-38. PubMed ID: 17015476
[TBL] [Abstract][Full Text] [Related]
31. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation.
Chen P; Luo C; Deng Y; Ryan K; Register J; Margosiak S; Tempczyk-Russell A; Nguyen B; Myers P; Lundgren K; Kan CC; O'Connor PM
Cell; 2000 Mar; 100(6):681-92. PubMed ID: 10761933
[TBL] [Abstract][Full Text] [Related]
32. Zebrafish as model system for the biological characterization of CK1 inhibitors.
Meier L; Gahr BM; Roth A; Gihring A; Kirschner S; Woitaske-Proske C; Baier J; Peifer C; Just S; Knippschild U
Front Pharmacol; 2023; 14():1245246. PubMed ID: 37753113
[No Abstract] [Full Text] [Related]
33. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
[TBL] [Abstract][Full Text] [Related]
34. Methods for studying checkpoint kinases - Chk1.
Tapia-Alveal C; O'Connell MJ
Methods Mol Biol; 2011; 782():171-9. PubMed ID: 21870291
[TBL] [Abstract][Full Text] [Related]
35. Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin.
Wolff S; Stöter M; Giamas G; Piesche M; Henne-Bruns D; Banting G; Knippschild U
FEBS Lett; 2006 Nov; 580(27):6477-84. PubMed ID: 17101137
[TBL] [Abstract][Full Text] [Related]
36. Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response.
Smits VA; Reaper PM; Jackson SP
Curr Biol; 2006 Jan; 16(2):150-9. PubMed ID: 16360315
[TBL] [Abstract][Full Text] [Related]
37. A novel function of hepatocyte growth factor in the activation of checkpoint kinase 1 phosphorylation in colon cancer cells.
Song N; Che X; Xu L; Qu J; Zheng H; Hou K; Qu X; Liu Y
Mol Cell Biochem; 2017 Dec; 436(1-2):29-38. PubMed ID: 28573382
[TBL] [Abstract][Full Text] [Related]
38. Site-specific casein kinase 1epsilon-dependent phosphorylation of Dishevelled modulates beta-catenin signaling.
Klimowski LK; Garcia BA; Shabanowitz J; Hunt DF; Virshup DM
FEBS J; 2006 Oct; 273(20):4594-602. PubMed ID: 16965538
[TBL] [Abstract][Full Text] [Related]
39. New potential peptide therapeutics perturbing CK1δ/α-tubulin interaction.
Krüger M; Kalbacher H; Kastritis PL; Bischof J; Barth H; Henne-Bruns D; Vorgias C; Sarno S; Pinna LA; Knippschild U
Cancer Lett; 2016 Jun; 375(2):375-383. PubMed ID: 26996302
[TBL] [Abstract][Full Text] [Related]
40. The phosphorylated C-terminal domain of Xenopus Cut5 directly mediates ATR-dependent activation of Chk1.
Hashimoto Y; Tsujimura T; Sugino A; Takisawa H
Genes Cells; 2006 Sep; 11(9):993-1007. PubMed ID: 16923121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
